IUCT Oncopole - Institut Claudius Regaud

Running trials

• Recruiting

  A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned

  NCT07665450· Phase 3· Source

• Active, not recruiting

  EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)

  NCT06923761· Phase 1/2· Source

• Recruiting

  Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib

  NCT03651206· Phase 2/3· Source

• Active, not recruiting

  Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients

  NCT04115007· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple myeloma1 recruiting
• Ovarian cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Multiorgan Metabolic Imaging Response Assessment of Abemaciclib

  NCT03339843· Phase 2· Source

• Completed

  Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer

  NCT03353831· Phase 3· Source